Huang-Kui capsules can inhibit the activation of NLRP3 and TLR4/NF-κB pathways, improving the epithelial–mesenchymal transition in the renal tubule in DKD rats [8]. This evidence concerns the gene NLRP3 and diabetic kidney disease.